BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 2474376)

  • 21. Persistence of resistant putative preneoplastic hepatocytes induced by N-nitrosodiethylamine or N-methyl-N-nitrosourea.
    Solt DB; Cayama E; Sarma DS; Farber E
    Cancer Res; 1980 Apr; 40(4):1112-8. PubMed ID: 7357542
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The isolation of monoclonal antibodies to hepatoma-associated nonhistone chromosomal proteins from rat kidneys].
    Grandilevskaia AB; Polyntsev DG; Kushner VP; Ivanov VA
    Tsitologiia; 1993; 35(9):57-61. PubMed ID: 8266582
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Detection of an altered form of cell-CAM 105 on rat transplantable and primary hepatocellular carcinomas.
    Hixson DC; McEntire KD
    Cancer Res; 1989 Dec; 49(23):6788-94. PubMed ID: 2684401
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Over-expression of protein kinase C delta is associated with a delay in preneoplastic lesion development in diethylnitrosamine-induced rat hepatocarcinogenesis.
    La Porta CA; Comolli R
    Carcinogenesis; 1995 May; 16(5):1233-8. PubMed ID: 7767990
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pleiotropic drug resistance in hepatocytes induced by carcinogens administered to rats.
    Carr BI
    Cancer Res; 1987 Nov; 47(21):5577-83. PubMed ID: 2889526
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cell proliferation induced by triiodothyronine in rat liver is associated with nodule regression and reduction of hepatocellular carcinomas.
    Ledda-Columbano GM; Perra A; Loi R; Shinozuka H; Columbano A
    Cancer Res; 2000 Feb; 60(3):603-9. PubMed ID: 10676643
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Influence of the vitamin D status on the early hepatic response to carcinogen exposure in rats.
    He RK; Gascon-Barré M
    J Pharmacol Exp Ther; 1997 Apr; 281(1):464-9. PubMed ID: 9103532
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Vanadium inhibits the development of 2-acetylaminofluorene-induced premalignant phenotype in a two-stage chemical rat hepatocarcinogenesis model.
    Chakraborty T; Chatterjee A; Saralaya MG; Dhachinamoorthi D; Chatterjee M
    Life Sci; 2006 May; 78(24):2839-51. PubMed ID: 16352317
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vivo differentiation of rat liver oval cells into hepatocytes.
    Evarts RP; Nagy P; Nakatsukasa H; Marsden E; Thorgeirsson SS
    Cancer Res; 1989 Mar; 49(6):1541-7. PubMed ID: 2466557
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Requirement of cell proliferation for the initiation of liver carcinogenesis as assayed by three different procedures.
    Columbano A; Rajalakshmi S; Sarma DS
    Cancer Res; 1981 Jun; 41(6):2079-83. PubMed ID: 6113048
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Initiation and selection of resistant hepatocyte nodules in rats given the pyrrolizidine alkaloids lasiocarpine and senecionine.
    Hayes MA; Roberts E; Farber E
    Cancer Res; 1985 Aug; 45(8):3726-34. PubMed ID: 2861891
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of acute hepatic necrosis in the induction of early steps in liver carcinogenesis by diethylnitrosamine.
    Ying TS; Sarma DS; Farber E
    Cancer Res; 1981 Jun; 41(6):2096-102. PubMed ID: 6113050
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression of the c-raf protooncogene, gamma-glutamyltranspeptidase, and gap junction protein in rat liver neoplasms.
    Beer DG; Neveu MJ; Paul DL; Rapp UR; Pitot HC
    Cancer Res; 1988 Mar; 48(6):1610-7. PubMed ID: 2894242
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Monoclonal antibodies directed against preneoplastic and neoplastic murine mammary lesions.
    Johnson CW; Wei WZ; Barth RF; Tuttle SE; Andrews CA
    Cancer Res; 1985 Aug; 45(8):3774-81. PubMed ID: 3893690
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Heterogeneity of hepatocyte antigen expression in rat liver carcinogenesis: concordance between neoplastic nodules and tumours.
    Embleton MJ; James HS; Haynes AJ; Butler PC
    Br J Exp Pathol; 1989 Dec; 70(6):647-57. PubMed ID: 2532534
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Epoxide hydrolase: a marker for experimental hepatocarcinogenesis.
    Griffin MJ; Gengozian N
    Ann Clin Lab Sci; 1984; 14(1):27-31. PubMed ID: 6696387
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Different responses to phenobarbital promotion in the development of gamma-glutamyltranspeptidase-positive foci in the liver of rats initiated with diethylnitrosamine, N-hydroxy-2-acetyl-aminofluorene and aflatoxin B1.
    Shirai T; Imaida K; Ohshima M; Fukushima S; Lee MS; King CM; Ito N
    Jpn J Cancer Res; 1985 Jan; 76(1):16-9. PubMed ID: 2857671
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Suppression of natural killer and lymphocyte functions associated with carcinogen-induced premalignant hyperplastic nodules in rat liver.
    Leu RW; Norton TR; Herriott MJ; Ringer DP; Kearns RJ
    Cancer Res; 1985 Jul; 45(7):3282-7. PubMed ID: 2860970
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Changes in polypeptide pattern of rat liver cells during chemical hepatocarcinogenesis.
    Sugioka Y; Fujii-Kuriyama Y; Kitagawa T; Muramatsu M
    Cancer Res; 1985 Jan; 45(1):365-78. PubMed ID: 3965145
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Correlation of c-myc overexpression and amplification with progression of preneoplastic liver lesions to malignancy in the poorly susceptible Wistar rat strain.
    De Miglio MR; Simile MM; Muroni MR; Pusceddu S; Calvisi D; Carru A; Seddaiu MA; Daino L; Deiana L; Pascale RM; Feo F
    Mol Carcinog; 1999 May; 25(1):21-9. PubMed ID: 10331741
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.